With over 85 microbiome-based, live biotherapeutic products under preclinical and clinical development

Given the anticipated increase in demand for vaccines, stakeholders are actively focusing on the development and validation of novel delivery devices

Proteome profiling is a technically complex and financially demanding field of research; as a result, both pharmaceutical companies and research institutes prefer to rely on specialty service providers that claim to have the required expertise

The approval of KYMRIAH�, YESCARTA�, Alofisel� and Zyntelgo� has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity

The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with the introduction of theranostics, has opened up opportunities for companies having capabilities to manufacture nuclear medicine and radiopharmaceuticals

Advances in 3D cell culturing, have led to the discovery of better scaffold fabrication techniques and also enabled various parts of the process to be automated; given their numerous benefits the adoption of such solutions it therefore, on the rise

Over the years, various industry stakeholders have actively invested in the development and implementation of automation technologies for manufacturing operations

Human factors engineering and usability testing have now become an essential part of product design across almost all industries, offering developers the chance to optimize proprietary products in alignment to the preferences of consumers

Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting

Rising demand for viral vectors coupled to lack of scalability and other concerns related to downstream purification

Growing awareness of the impending energy crisis and the need to reduce carbon emissions, have led to the development of AI-based technologies to facilitate optimal power consumption and adoption of energy efficient infrastructure

Despite mammalian cell cultures being the preferred manufacturing approach for biologics, recent advances in microbial fermentation have enabled the development of versatile biomanufacturing systems